NOV03 Archives - OptikNow

Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03

Wednesday, October 6 2021 | 11 h 29 min | News, Press Release

Bausch + Lomb and Novaliq announced statistically significant topline data from the second Phase 3 (MOJAVE) trial evaluating the investigational...

Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Thursday, April 15 2021 | 09 h 33 min | Dry Eye, News, Press Release

Bausch + Lomb and Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, announced statistically significant...

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

Vision Expo East 2025 will offer new conference programming for professional development in the eyecare and eyewear industry, offering over 270 hours of accredited and non-accredited education tailored to the needs of ophthalmologists, optometrists, opticians and allied professionals.

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

The renewal is a testament to strong confidence, trust and collaboration between the two companies

Learn More

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

This marks a key milestone in the Company’s efforts to reduce the environmental impact across its entire value chain.

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

EssilorLuxottica strengthens its portfolio of advanced high-quality vision care instruments and certified medical technologies, with innovative solutions for dry-eye and other diseases

NOW Trend Showcase Submission Deadline Extended to January 2025

The submission deadline for the NOW Trend Showcase and Awards at Vision Expo East 2025 has been extended to January 17, 2025.

Tag: NOV03

Bausch + Lomb Announces Statistically Significant Topline Results from Second Phase 3 Trial of NOV03

Bausch + Lomb Announces Results from First Phase 3 Trial of NOV03

Featured Posts

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025

Prada Group and EssilorLuxottica Announce Ten-year Licensing Renewal

EssilorLuxottica’s greenhouse gas emissions reduction targets validated by the Science Based Targets Initiative (SBTi)

Eye-Opening Education at Vision Expo East 2025

EssilorLuxottica Signs Agreement to Acquire Espansione Group for Accelerating Its Growth in the Med-tech Space

NOW Trend Showcase Submission Deadline Extended to January 2025